Guardion Health Sciences: A Look at Financial Results for Q2 2022
Guardion Health Sciences Announces Highest Quarterly Revenue in Company History Viactiv® Product Line Drives Growth Guardion Health Sciences, Inc. (Nasdaq: GHSI) has reported record-breaking revenue of approximately $3.275 million for the most recent quarter. This marks a significant increase from the previous quarter and showcases the company’s continued growth and success in the market. Company…